These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15995934)
1. Drug discovery technology. Start-up companies. Kubinyi H IDrugs; 2001 Jul; 4(7):783-7. PubMed ID: 15995934 [No Abstract] [Full Text] [Related]
2. Drug discovery technology 2002. Start-up showcase and structure-based drug design. Jones E; Mongin-Bulewski C IDrugs; 2002 Sep; 5(9):894-5. PubMed ID: 14686398 [No Abstract] [Full Text] [Related]
3. Opportunities and challenges in the discovery of new central nervous system drugs. Krause JE; Chenard BL Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381 [TBL] [Abstract][Full Text] [Related]
4. Patent holdings of US biotherapeutic companies in major markets. Sebastian TE; Yerram CB; Saberwal G Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502 [TBL] [Abstract][Full Text] [Related]
6. siRNAs in drug discovery: target validation and beyond. Natt F Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022 [TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in drug discovery and development. Stratowa C; Wilgenbus KK Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863 [TBL] [Abstract][Full Text] [Related]
8. Future antibiotics scenarios: is the tide starting to turn? Theuretzbacher U Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202 [TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
10. Chemical genetics and genomics and drug discovery. Highlights from the Society for Medicines Research symposium held Thursday March 10, 2005, in London, United Kingdom. Williams R; Brown K Drug News Perspect; 2005 May; 18(4):285-8. PubMed ID: 16034486 [TBL] [Abstract][Full Text] [Related]
11. Digital pathology in drug discovery and development: multisite integration. Potts SJ Drug Discov Today; 2009 Oct; 14(19-20):935-41. PubMed ID: 19596461 [TBL] [Abstract][Full Text] [Related]
12. Scientific workflows as productivity tools for drug discovery. Shon J; Ohkawa H; Hammer J Curr Opin Drug Discov Devel; 2008 May; 11(3):381-8. PubMed ID: 18428092 [TBL] [Abstract][Full Text] [Related]
13. Brazil: An emerging partner in drug R&D. Rodrigues DG IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884 [TBL] [Abstract][Full Text] [Related]
15. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method]. Naraoka H; Suzumura K; Takeuchi K; Sasayama T Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969 [TBL] [Abstract][Full Text] [Related]
16. A decade of fragment-based drug design: strategic advances and lessons learned. Hajduk PJ; Greer J Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284 [TBL] [Abstract][Full Text] [Related]
17. Predictive toxicology in drug discovery--second international conference. New technologies for predicting toxic responses at an early stage. 10-11 November 1999, New Orleans, LA, USA. Tugwood J IDrugs; 2000 Feb; 3(2):179-81. PubMed ID: 16107935 [TBL] [Abstract][Full Text] [Related]
20. Non-coding RNAs and new opportunities for the private sector. Costa FF Drug Discov Today; 2009 May; 14(9-10):446-52. PubMed ID: 19429503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]